Long Acting Pamorelin 11.25 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Long Acting Pamorelin 11.25 mg, covering 2014-05-26 to 2014-05-26. Get the full timeline:
Most recent: Clinical Trial Update: Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg [Phase 2]